Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland — a qualitative study

BACKGROUND: Fingolimod is an oral multiple sclerosis drug that is considered a specialty drug due to its high cost and safety issues. The Fingolimod Patient Support Program (F-PSP) is a specialty pharmacy service developed to ensure the responsible use of fingolimod by promoting patient safety and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourdin, Aline, Dubois, Julie, Foley, Rose-Anna, Schluep, Myriam, Bugnon, Olivier, Berger, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227186/
https://www.ncbi.nlm.nih.gov/pubmed/32410681
http://dx.doi.org/10.1186/s12913-020-05278-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227186/
https://www.ncbi.nlm.nih.gov/pubmed/32410681
http://dx.doi.org/10.1186/s12913-020-05278-3

Ejemplares similares